Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care    FME   DE0005785802

FRESENIUS MEDICAL CARE (FME)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/18/2017 10/19/2017 10/20/2017 10/23/2017 10/24/2017 Date
82.05(c) 82.58(c) 82.87(c) 83.09(c) 83.26 Last
450 081 470 291 479 883 373 022 137 508 Volume
+0.86% +0.65% +0.35% +0.27% +0.20% Change
More quotes
Financials (€)
Sales 2017 17 579 M
EBIT 2017 2 562 M
Net income 2017 1 234 M
Debt 2017 7 187 M
Yield 2017 1,22%
Sales 2018 18 967 M
EBIT 2018 2 762 M
Net income 2018 1 350 M
Debt 2018 7 040 M
Yield 2018 1,29%
P/E ratio 2017 20,44
P/E ratio 2018 18,82
EV / Sales2017 1,86x
EV / Sales2018 1,72x
Capitalization 25 589 M
More Financials
Company
Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure.Its products include dialysis machines, dialyzers, and related disposables.It also offers renal information technology solutions and provides services such as renal replacement therapy and... 
More about the company
Surperformance© ratings of Fresenius Medical Care
Trading Rating : Investor Rating :
More Ratings
Latest news on FRESENIUS MEDICAL CARE
10/20 KB Exchange Trust Acquires 14 Healthcare-Related Properties in 10 States
10/19 FRESENIUS MEDICAL CARE : Patent Issued for Apparatus and Method for the Vibrator..
10/19 FRESENIUS MEDICAL CARE : Patent Issued for Concentrate Container Having Supporti..
10/19 NXSTAGE MEDICAL, INC. : Other Events (form 8-K)
10/19 NXSTAGE MEDICAL, INC. (NASDAQ : NXTM) Files An 8-K Other Events
10/05 FRESENIUS MEDICAL CARE : Top Executives from Fresenius Medical Care North Americ..
10/05 FRESENIUS MEDICAL CARE : State board approves CON for Madison dialysis center
10/02 QUEST DIAGNOSTICS : Fresenius Medical Care AG & Co. - Fresenius Medical Care div..
09/29 FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 26a of the W..
09/28 FRESENIUS MEDICAL CARE : Patent Application Titled "Amperometric Creatinine Bios..
More news
Sector news : Healthcare Facilities & Services - NEC
10/23 European stocks hold firm as banks, Spanish shares fall
10/23 Spire rejects 1.2 billion pound Mediclinic offer, shares soar
10/22 MEDICLINIC INTERNATIONAL : approaches Spire about takeover - source
10/17 FTSE inches down, Merlin collapses on poor summer trading
10/05 Sterling slide boosts Britain's FTSE, basic resources, oil stocks jump
More sector news : Healthcare Facilities & Services - NEC
4-Traders Strategies on FRESENIUS MEDICAL CARE 
FRESENIUS MEDICAL CARE - 10/20
The technical configuration is positive
BUY
FRESENIUS MEDICAL CARE - 09/04
Comeback of a rising trend ?
BUY
More Strategies
Latest Tweets
10/23Fresenius SE & Co KGaA given €82.00 PT by Oddo Bhf. buy rating.  
10/20Fresenius Medical Care AG & Co. (Pref) given €95.40 PT by J P Morgan Chas.. 
10/20Fresenius Medical Care AG & Co. (Pref) given €83.00 PT by Deutsche Bank A.. 
10/20Fresenius SE & Co KGaA given €84.00 PT by Deutsche Bank AG. buy rating.  
10/19Fresenius SE & Co KGaA given €83.00 PT by Citigroup Inc.. buy rating.  
More tweets
Qtime:214
News from SeekingAlpha
10/09 MY JOURNEY TO FINANCIAL INDEPENDENCE : 83-Stock September Portfolio Update - Buy..
09/28 Quest Diagnostics to acquire Shiel Medical Laboratory from Fresenius Medical ..
09/22 DaVita under pressure on SIRF report on patient co-pay scheme
09/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 81-Stock August Portfolio Update - Buying..
09/07 Fresenius Medical Care (FMS) Presents At 2017 Wells Fargo Healthcare Conferen..
Chart FRESENIUS MEDICAL CARE
Duration : Period :
Fresenius Medical Care Technical Analysis Chart | FME | DE0005785802 | 4-Traders
Technical analysis trends FRESENIUS MEDICAL CARE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 88,7 €
Spread / Average Target 6,8%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Dieter Schenk Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS MEDICAL CARE3.28%30 077
HCA HEALTHCARE INC9.09%29 279
LABORATORY CORP. OF AMERICA HOLDINGS18.18%15 541
QUEST DIAGNOSTICS INC3.46%12 959
DAVITA INC-4.98%11 348
UNIVERSAL HEALTH SERVICES, INC.6.19%10 798